01.11.1998
ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither
C. Baigent, R. Collins, P. Appleby, S. Parish, P. Sleight, R. Peto on behalf of the ISIS-2 (Second International Study of Infarct Survival) Collaborative Group
British Medical Journal, 1998; 316: 1337-1343